# Nomocan Pharmaceuticals LLC

Canonical: https://abierto.us/vendors/nomocan-pharmaceuticals-llc-h9t8m7zbyar8

- UEI: H9T8M7ZBYAR8
- CAGE: 7ER28
- Location: New York, NY
- Awards in window: 1 (1 transactions), $0 obligated, September 1, 2026 to September 1, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00050 (definitive contract): $0, NIH NCI. Eo 14398; Nomocan Phase I - Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers And/Or Rare Cancers SBIR Contract Phase I - Development of Therapeutic or Preventative Technologies for Treatment or. https://www.usaspending.gov/award/CONT_AWD_75N91025C00050_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/nomocan-pharmaceuticals-llc-h9t8m7zbyar8.